M. S. Nascimento

High sensitivity and reproducibility of in‐house ELISAs using different genotypes of Trypanosoma cruzi

A. Llanes, Z. Caballero E, R. Correa, 2019, Parasite immunology.

Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas' disease in Bolivia.

J. F. da Silveira, C. R. Zárate-Bladés, M. S. Nascimento, 2007, Diagnostic microbiology and infectious disease.

STING Signaling Drives Production of Innate Cytokines, Generation of CD8+ T Cells and Enhanced Protection Against Trypanosoma cruzi Infection

N. Câmara, G. Barber, J. Kalil, 2022, Frontiers in Immunology.

Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo

J. Kalil, L. Freitas-Junior, B. Zingales, 2022, Antimicrobial agents and chemotherapy.

Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease.

M. S. Nascimento, E. Umezawa, A. M. Stolf, 2001, Diagnostic microbiology and infectious disease.

Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease

J. Coura, A. Junqueira, M. S. Nascimento, 1996, Journal of clinical microbiology.

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy

J. Kalil, E. Cunha-Neto, M. S. Nascimento, 2018, Front. Immunol..

Vimentin and Anti Vimentin Antibodies in Chagas' Disease

H. F. de Andrade Júnior, M. S. Nascimento, R. Pandey, 2018, Arquivos brasileiros de cardiologia.

New Approaches for the Treatment of Chagas Disease.

J. Kalil, C. Moore, E. Cunha-Neto, 2020, Current Drug Targets.